Simbec-Orion Group Ltd is a clinical research organization (CRO) that provides clinical trial management services. The company’s capabilities consist of scintigraphy services, pharmacovigilance, clinical trial data management and biometric services, central laboratory services, clinical pharmacology, and clinical development. It carries out a range of studies covering first-in-human (FIH), food effect, drug-drug interaction, and pharmacokinetic studies. The company’s clinical pharmacology unit includes an investigational medicinal product management capability and an on-site bioanalytical and clinical pathology laboratory service. Simbec-Orion’s clinical development solution helps manage clinical trials with products comprising vaccines, new chemical entities (NCEs), antisense therapy, small molecules, peptides, and antibodies. It covers treatment areas such as oncology, rare and orphan diseases, respiratory, dermatology, and anti-infectives. The company’s clinical trial laboratory services consist of biochemistry, including urinalysis, haematology and coagulation, biomarker analysis, and Covid-19 screening. Its pharmacovigilance specialists, through the collection and continuous evaluation of clinical safety data throughout the clinical development process, assess and monitor the incidence of adverse drug reactions (ADRs). Its biometrics team provides adaptive clinical data management services for drug development initiatives.